An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor
Clinical trial NCT00441610 · COMPLETED
Trial details
- NCT number
- NCT00441610
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.